Benazepril Hydrochloride

盐酸贝那普利

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBenazepril Hydrochloride
Drug Alias Name贝那普利盐酸ZAPRACEBenazeprilum Hydrochloride盐酸苯那普利Cibacene +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertensionHeart FailureNephritis
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryN/A
Original Approved Date1989/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUs Pharm Holdings
China Registration ClassN/A

Develop Information

Active CompaniesValidus PharmaceuticalsUs Pharm HoldingsBeijing Novartis Pharma Co Ltd
Inactive CompaniesNovartis Pharma AgHenan University Of Traditional Chinese Medicine
Active IndicationsHypertensionHeart Failure
Inactive IndicationsNephritis

Other Information

ATC CodeC09AA07
Related LinksWikipediaDrugBankKEGG